Mira Pharmaceuticals (MIRA) Accounts Payables (2022 - 2025)

Mira Pharmaceuticals has disclosed Accounts Payables across 4 years of filings, most recently posting $129203.0 for Q4 2025.

• Accounts Payables for Q4 2025 came in at $129203.0, down 82.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $129203.0 (down 82.14% YoY), and the FY2025 annual result was $129203.0, down 82.14% from the prior year.
• Accounts Payables came in at $129203.0 for Q4 2025 at Mira Pharmaceuticals, up from $83926.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $811738.0 in Q4 2022 to a low of $83926.0 in Q3 2025.
• The 4-year median for Accounts Payables is $636261.0 (2024), against an average of $494520.2.
• Across the five-year window, Accounts Payables surged 34.31% in 2024 and sank 87.89% in 2025, its largest moves.
• Mira Pharmaceuticals' Accounts Payables stood at $811738.0 in 2022, then slumped by 33.65% to $538564.0 in 2023, then surged by 34.31% to $723349.0 in 2024, then tumbled by 82.14% to $129203.0 in 2025.
• The last three Accounts Payables figures came in at $129203.0 (Q4 2025), $83926.0 (Q3 2025), and $298459.0 (Q2 2025), per Business Quant data.